Activated B cells targeted to
autoantigens proliferate and differentiate into antibody-secreting cells. Overproduced
autoantibodies will give rise to
autoimmune diseases. In this study, we investigated the inhibitory effects of GYF-21, an
epoxide 2‑(2‑phenethyl)‑chromone derivative extracted from Chinese agarwood, on the survival, activation, proliferation, and differentiation of B cells for revealing its potential to treat
autoimmune diseases related to B cell dysfunction. The results showed that GYF-21 slightly inhibited the survival, activation and proliferation of B cells stimulated by combination of
anti-IgM, anti-CD40 and
IL-4 while weakly up-regulated differentiation of B cells induced by combination of anti-CD40 and
IL-4. In addition, GYF-21 intensively suppressed survival, activation, proliferation, and differentiation of B cells stimulated by
B-cell activating factor (BAFF) which plays extremely important roles in
autoantibody production and pathogenesis of
autoimmune diseases. The mechanism study revealed that GYF-21 slightly down-regulated phosphorylation of NF-κB p65, Akt, STAT3, but up-regulated phosphorylation of Erk1/2 in B cells activated by
anti-IgM, anti-CD40,
IL-4 or their combinations. However, GYF-21 not only moderately down-regulated phosphorylation of NF-κB p65 and
MAPK p38, but also intensively inhibited phosphorylation of Erk1/2 and Akt induced by BAFF. These data suggest the inhibitory effects of GYF-21 on the survival, activation, proliferation, and differentiation of B cells mainly via blocking BAFF activated signaling pathways, and its potential to be developed into therapeutic
drug for
autoimmune diseases, especially
systemic lupus erythematosus (SLE).